Search results
FDA advisory panel votes against allowing MDMA as PTSD treatment
UPI· 6 hours agoThe popular underground drug midomafetamine, also called MDMA and "ecstasy," failed to win an...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
AOL· 9 hours agoThe two votes — one for the treatment’s efficacy and one for its safety, by the agency’s Psychopharmacologic Drugs Advisory Committee — marked the first time that FDA advisers ...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoThe current predominant strain of COVID-19 should be a key consideration during the upcoming meeting...
FDA advisers consider MDMA therapy to treat PTSD - WSVN 7News | Miami News, Weather, Sports | Fort...
7 News Miami· 19 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel...
FDA advisers consider MDMA therapy to treat PTSD
WKBT La Crosse· 20 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform a field...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Medical Xpress· 14 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 1 day agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
FDA panel rejects first MDMA-based PTSD treatment
USA TODAY via Yahoo News· 7 hours agoOver 190 patients, who received doses of MDMA in addition to therapy, showed a significant reduction in PTSD scores compared to placebo. The FDA's staff reviewers on Friday ...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 5 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
FDA Platform Technology Designation Program aims to speed development of drugs, biological products...
JD Supra· 1 day agoFDA developed the new platform technology designation program draft guidance to fulfill its requirement under Section 506K(b) of the Federal Food, Drug, and Cosmetic Act ( ...